Keyphrases
Active Species
16%
Adjuvant Activity
16%
Antitumor Activity
33%
Bone Marrow Cells
8%
Bone Marrow-derived Dendritic Cells
16%
Cationic Lipids
100%
Cervical Cancer
8%
Chemokine (C-C motif) Ligand 2 (CCL2)
33%
Chemokine CCL2
16%
Chemokine CCL4
16%
CTL Activity
8%
Dendritic Cells
50%
DOTAP
100%
ERK Activation
16%
Extensive Structure
16%
Formulation Improvement
16%
Highly Active
8%
Human Cervical Cancer
16%
Improvement Strategies
16%
Interleukin-12 (IL-12)
33%
Lipid Adjuvants
16%
Lipids
16%
MEK1
16%
Mitogen-activated Protein Kinase
8%
Mouse Model
8%
Nanoparticle Formulation
16%
Oncogene
8%
Oxygen Species Activation
16%
P38 Activation
33%
Peptide Antigen
16%
Phosphorylation
8%
Primary Bone
8%
Public Health
8%
Reactive Oxygen Species
25%
Signal Transduction
8%
Small Interfering RNA (siRNA)
8%
Specific Inhibitor
8%
Structure-activity Relationship Studies
16%
Targeted Nanoparticles
8%
TC-1 Tumor
33%
Therapeutic Vaccine
25%
Transfection Reagent
16%
Tumor Cells
8%
Upstream Kinases
16%
Vaccine Formulation
16%
Well-defined
8%
Pharmacology, Toxicology and Pharmaceutical Science
1,2 Dioleoyl 3 Trimethylammoniopropane
100%
Antitumor Activity
16%
Macrophage Inflammatory Protein 1beta
16%
Malignant Neoplasm
8%
Mitogen Activated Protein Kinase P38
16%
Monocyte Chemotactic Protein 1
16%
Mouse Model
8%
Nanoparticle
8%
Neoplasm
25%
Phosphotransferase
8%
Reactive Oxygen Metabolite
25%
Small Interfering RNA
8%
Structure Activity Relationship
16%
Therapeutic Vaccine
33%
Tumor Vaccine
16%
Uterine Cervix Cancer
33%
Vasculotropin
16%